Journal of pediatric hematology/oncology · 2001
Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism.
Клинический случайСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Silfen M E, Garvin J H, Hays A P, Starkman H S, Aranoff G S, Levine L S, Feldstein N A, Wong B, Oberfield S E
Аннотация
We report a 15-year-old boy who had isolated central diabetes insipidus initially diagnosed at age 11 years. A brain magnetic resonance imaging (MRI) was normal at the time. At age 12 years, growth hormone (GH) testing was performed because of a decline in linear growth rate and demonstrated GH deficiency. After a repeat normal brain MRI, GH therapy was begun. Three years later, hormonal testing revealed prepubertal gonadotropins and low testosterone levels, free thyroxine index, and morning cortisol levels. Repeat brain MRI demonstrated a 9-mm enhancing lesion in the region of the pituitary stalk. The pathologic diagnosis was that of a high-grade malignant B-cell lymphoma, suggestive of Burkitt Lymphoma. Growth hormone therapy has not been associated with an increased incidence of lymphoma. This report underscores the need for vigilance in follow-up brain imaging and hormonal evaluation in children with diabetes insipidus, especially those with evolving anterior hormone deficiencies.
Предметные рубрики MeSH
AdolescentAntineoplastic Combined Chemotherapy ProtocolsBurkitt LymphomaCyclophosphamideCytarabineDiabetes InsipidusDisease ProgressionDoxorubicinDwarfism, PituitaryFalse Negative ReactionsGenetic Predisposition to DiseaseHuman Growth HormoneHumansHydrocortisoneHypopituitarismHypothyroidismLymphoma, Non-HodgkinMagnetic Resonance ImagingMaleMethotrexatePituitary HormonesPituitary NeoplasmsPrednisoneRemission InductionVincristine